These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 20017804

  • 1. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB, Czerkinsky C, Holmgren J.
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [Abstract] [Full Text] [Related]

  • 2. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB, Cuburu N, Blomquist M, Li BL, Czerkinsky C, Holmgren J.
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [Abstract] [Full Text] [Related]

  • 3. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
    Sun JB, Czerkinsky C, Holmgren J.
    Scand J Immunol; 2007 Sep; 66(2-3):278-86. PubMed ID: 17635805
    [Abstract] [Full Text] [Related]

  • 4. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
    Sun JB, Czerkinsky C, Holmgren J.
    J Immunol; 2012 Feb 15; 188(4):1686-97. PubMed ID: 22250081
    [Abstract] [Full Text] [Related]

  • 5. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
    Sun JB, Flach CF, Czerkinsky C, Holmgren J.
    J Immunol; 2008 Dec 15; 181(12):8278-87. PubMed ID: 19050244
    [Abstract] [Full Text] [Related]

  • 6. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
    Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, Mizushima Y, Holmgren J, Lehner T.
    Clin Exp Immunol; 2004 Jul 15; 137(1):201-8. PubMed ID: 15196263
    [Abstract] [Full Text] [Related]

  • 7. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB, Li BL, Czerkinsky C, Holmgren J.
    Clin Immunol; 2000 Nov 15; 97(2):130-9. PubMed ID: 11027453
    [Abstract] [Full Text] [Related]

  • 8. Oral tolerance: therapeutic implications for autoimmune diseases.
    Faria AM, Weiner HL.
    Clin Dev Immunol; 2006 Nov 15; 13(2-4):143-57. PubMed ID: 17162357
    [Abstract] [Full Text] [Related]

  • 9. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, Rudling M, Ketelhuth DF, Gerdes N, Holmgren J, Nilsson J, Hansson GK.
    Arterioscler Thromb Vasc Biol; 2010 May 15; 30(5):946-52. PubMed ID: 20167655
    [Abstract] [Full Text] [Related]

  • 10. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N.
    Ann N Y Acad Sci; 2004 Dec 15; 1029():193-208. PubMed ID: 15681758
    [Abstract] [Full Text] [Related]

  • 11. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J, Adamsson J, Anjuère F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S.
    Immunol Lett; 2005 Mar 15; 97(2):181-8. PubMed ID: 15752556
    [Abstract] [Full Text] [Related]

  • 12. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A, Hultkrantz S, Raghavan S, Czerkinsky C, Lebens M, Telemo E, Holmgren J.
    Immunology; 2006 Jul 15; 118(3):311-20. PubMed ID: 16827892
    [Abstract] [Full Text] [Related]

  • 13. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
    Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P.
    Gastroenterology; 2007 Aug 15; 133(2):517-28. PubMed ID: 17681173
    [Abstract] [Full Text] [Related]

  • 14. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y, Hara-Yakoyama C, Guadiz AA, Udaka S, Kiyono H, Chatterjee S.
    Biotechnol Bioeng; 2005 Dec 30; 92(7):803-9. PubMed ID: 16142801
    [Abstract] [Full Text] [Related]

  • 15. ADP-ribosylation controls the outcome of tolerance or enhanced priming following mucosal immunization.
    Hasselberg A, Ekman L, Yrlid LF, Schön K, Lycke NY.
    J Immunol; 2010 Mar 15; 184(6):2776-84. PubMed ID: 20142362
    [Abstract] [Full Text] [Related]

  • 16. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
    Kim PH, Eckmann L, Lee WJ, Han W, Kagnoff MF.
    J Immunol; 1998 Feb 01; 160(3):1198-203. PubMed ID: 9570534
    [Abstract] [Full Text] [Related]

  • 17. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM.
    Am J Trop Med Hyg; 1994 Feb 01; 50(5 Suppl):42-54. PubMed ID: 8203723
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM, Alard P, Liang S, Clark SL.
    Int Immunol; 2004 May 01; 16(5):697-706. PubMed ID: 15096489
    [Abstract] [Full Text] [Related]

  • 19. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E, Westrich GM, Viney JL.
    J Immunol; 1999 Oct 01; 163(7):3668-75. PubMed ID: 10490961
    [Abstract] [Full Text] [Related]

  • 20. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB, Raghavan S, Sjöling A, Lundin S, Holmgren J.
    J Immunol; 2006 Dec 01; 177(11):7634-44. PubMed ID: 17114433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.